FDA Inspection 642855 — Claris Lifesciences Inc
The FDA completed an inspection of Claris Lifesciences Inc on Feb 2, 2010 in North Brunswick, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Feb 2, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- North Brunswick, NJ (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)
Citations
| ID | CFR | Description |
|---|---|---|
| 6829 | 21 CFR 314.80(c)(2) | Failure to report non-alert ADEs |
| 6833 | 21 CFR 314.80(c)(2)(ii)(A) | Incomplete periodic safety report |
| 6841 | 21 CFR 314.80(f)(1) | Incomplete patient information on ICSR |